Olympus 2012 Annual Report Download - page 27

Download and view the complete annual report

Please find page 27 of the 2012 Olympus annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 105

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105

sharp cutting edges and unique hemostasis capabilities. We will replace existing devices with new devices
and create a new market by applying highly superior technologies that competitors cannot imitate.
Furthermore, we will steadily expand our business in this field by taking maximum advantage of the Gyrus’
powerful sales network.
By geographical region, sales expansion in high-growth emerging markets is the key to growth in the
Medical Business. In these markets, we aim for high average annual growth of 23%. What is important in
emerging markets is to increase the number of physicians who are able to use endoscopes. To meet this
need, we will establish more than twenty training centers in Asia and further accelerate the training of
endoscopic physicians and dissemination of endoscopic procedures.
>>> Growth Strategies for the Life Science & Industrial Business
We aim for average annual growth of 5% in sales and 21% in operating income from profit improvement in
the life science field and product portfolio expansion in the industrial field.
One growth strategy is product portfolio expansion. The vertical axis in the graph below indicates
customer industry categories, and the horizontal axis indicates technologies and product categories. We will
leverage the Olympus Group’s global infrastructure to efficiently open up new customers (in the direction of
the arrow). Similarly, we will open up new business fields and expand our business by acquiring new
technologies and products. In addition, we will focus on emerging countries, which are growth markets.
The second strategy is full-fledged reform of the profit structure of the life science field. For instance,
Proactive Expansion of the Product Portfolio
Effectively expand business fields based on the needs of customer industries and technologies/products
by leveraging the Olympus Group’s global infrastructure
Energy
Technology/Product
Customer Industries
Aviation and transportation
Metals and manufacturing
Research and pathological diagnosis
Resources and recycling
Microscopes Endoscopes Ultrasound X-ray analysis
Development of new markets
Development of new markets
in new industries
in new industries
Sales expansion by entering
untapped industries
Development of new markets in
new industries
Development of new business
fields through acquisition of new
technologies and products
Development of new business fields
through the acquisition of new
technologies and products
OLYMPUS 󱚈 Annual Report 2012 25